New injection could replace IV drips for leukemia patients
NCT ID NCT07223190
Summary
This study is testing if a new under-the-skin injection of the drug blinatumomab works as well as the standard intravenous (IV) drip version. It will involve 560 adults newly diagnosed with a specific type of leukemia. The main goal is to see if the injection is just as effective at helping patients live longer when given alongside chemotherapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PHILADELPHIA CHROMOSOME NEGATIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.